Purpose
To produce low-cost monoclonal antibodies to protect vulnerable populations in LMICs from infectious diseases including malaria and RSV
Grantee
Division
Global Health
Date
NOVEMBER 2024
Region served
GLOBAL
Committed amount
$3,092,136
Grant topic
Discovery and Translational Sciences,
Vaccine Development
Duration (months)
21
Grantee location
Jupiter, FL, United States
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.